CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

Reyes Gonzalez-Exposito; Maria Semiannikova; Beatrice Griffiths; Khurum Khan; Louise J. Barber; Andrew Woolston; Georgia Spain; Katharina von Loga; Ben Challoner; Radhika Patel; Michael Ranes; Amanda Swain; Janet Thomas; Annette Bryant; Claire Saffery; Nicos Fotiadis; Sebastian Guettler; David Mansfield; Alan Melcher; Thomas Powles; Sheela Rao; David Watkins; Ian Chau; Nik Matthews; Fredrik Wallberg; Naureen Starling; David Cunningham; Marco Gerlinger

doi:10.1186/s40425-019-0575-3

Citation Tools

XML

Research Article

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Gonzalez-Exposito R, Semiannikova M, Griffiths B, et al

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

Journal for ImmunoTherapy of Cancer 2019;7:101. doi: 10.1186/s40425-019-0575-3

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password